Inlyta is prescribed to help slow down the progression of advanced renal cell carcinoma (kidney cancer) when other chemotherapy treatments have failed. Side effects may include fatigue, diarrhea, and nausea. This medication comes as a tablet that is taken twice a day, with 12 hours between doses. Your specific dosage will depend on how you tolerate the drug, other medications you are taking, and other factors.
What Is Inlyta?Inlyta® (axitinib) is a prescription medication approved for the treatment of advanced renal cell carcinoma (kidney cancer) that has not responded to one or more other kidney cancer medications. It belongs to a group of medicines called kinase inhibitors.
(Click Inlyta Uses for more information on what this medication is used for, including possible off-label uses.)